![David Foureau: My deepest gratitude to the Purple Promise Foundation for their continued support of our melanoma immunotherapy research program](https://oncodaily.com/pub/uploads/2024/02/1708013062097.png)
Photo taken from: David Foureau/LinkedIn
Feb 17, 2024, 19:52
David Foureau: My deepest gratitude to the Purple Promise Foundation for their continued support of our melanoma immunotherapy research program
David Foureau, Associate Professor, Research Group Director at Levine Cancer Institute Atrium Health, posted the following on LinkedIn:
“My deepest gratitude to the Purple Promise Foundation for their continued support of our melanoma immunotherapy research program. This $100,000 grant will be used to study strategies to redirect immunotherapy for recurring melanoma patients.”
Source: David Foureau/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023